Trials / Completed
CompletedNCT01960634
Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (actual)
- Sponsor
- Grupo Español Multidisciplinar de Melanoma · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a multi-centric translational study with biological samples collection. The aim of this study is to validate a method to detect BRAFV600 in blood samples. Samples: Blood from patients with BRAFV600 metastatic melanoma collected following standard medical practice. The treatment is not the aim of the study. Patients can be treated either with specific or no-specific drug.
Conditions
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2013-10-10
- Last updated
- 2015-05-05
Locations
13 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01960634. Inclusion in this directory is not an endorsement.